Prime Medicine

4 followers


Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and r... Read more

Industries

Employees

51-200

Links


Org chart

Andrew Anzalone
Co-Founder & Head of Prime Editing Platform
Carman Alenson
CAO & SVP, Finance
Mohammed Asmal
SVP & Head of Clinical
Meredith Goldwasser
SVP & Head of Strategy & Corporate Operations
Chris Bell
Vice President
Yune Kunes
Vp, Head Of Analytical Development, Formulation And Early Stage QC
John R. Hadcock, Ph.D.
Vice President, Nonclinical Development At Prime Medicine
Yi Pu
Group Head
Barrett Nehilla
Sr Director, Cell Therapy Process Development & Head Of CMC Portfolio Management
Alexandria Petrusich
Vice President Clinical Science
Jennifer Gori
Vice President And Head Of Hematology & Immunology
Robert Greene
Senior Director, Head Of External Manufacturing

Board & advisors

Michael Kelly
Board Member
Kaye Foster
Board Member (nasdaq: Prime)
Thomas Cahill
Board Member
Wendy Chung
Board Member
Robert Nelsen
Board Member
David Schenkein
Board Member
David R. Liu
Co-Founder & SAB Chair
Eric N. Olson
Scientific Advisor
Muthiah Manoharan
Scientific Advisor
Guangping Gao
Scientific Advisor
Jim Haber
Scientific Advisor
Agnieszka Czechowicz
Scientific Advisor
Yvonne Chen
Scientific Advisor
Ben Kleinstiver
Scientific Advisor
Anastasia Khvorova
Scientific Advisor
Shengdar Tsai
Scientific Advisor
Jay Shendure
Scientific Advisor
Samuel Sternberg
Scientific Advisor
Jeff Marrazzo
Board Member